These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Comparing sensitivity to change using the 6-item versus the 17-item Hamilton depression rating scale in the GUIDED randomized controlled trial. Dunlop BW; Parikh SV; Rothschild AJ; Thase ME; DeBattista C; Conway CR; Forester BP; Mondimore FM; Shelton RC; Macaluso M; Logan J; Traxler P; Li J; Johnson H; Greden JF BMC Psychiatry; 2019 Dec; 19(1):420. PubMed ID: 31881956 [TBL] [Abstract][Full Text] [Related]
10. Does Pharmacogenomic Testing Improve Clinical Outcomes for Major Depressive Disorder? A Systematic Review of Clinical Trials and Cost-Effectiveness Studies. Rosenblat JD; Lee Y; McIntyre RS J Clin Psychiatry; 2017 Jun; 78(6):720-729. PubMed ID: 28068459 [TBL] [Abstract][Full Text] [Related]
11. Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial). Minelli A; Barlati S; Vitali E; Bignotti S; Dattilo V; Tura GB; Maffioletti E; Giacopuzzi E; Santoro V; Perusi G; Cobelli C; Magri C; Bonizzato S; Bocchio-Chiavetto L; Spina E; Vita A; Gennarelli M Trials; 2021 Dec; 22(1):896. PubMed ID: 34895291 [TBL] [Abstract][Full Text] [Related]
12. The effect of pharmacogenomic testing on response and remission rates in the acute treatment of major depressive disorder: A meta-analysis. Rosenblat JD; Lee Y; McIntyre RS J Affect Disord; 2018 Dec; 241():484-491. PubMed ID: 30149336 [TBL] [Abstract][Full Text] [Related]
13. Editorial: Beyond Red Light, Green Light: Examining the Role of Pharmacogenomics in Evidence-Based Care in Child and Adolescent Psychiatry. Namerow LB; Ramsey LB; Malik S; Cortese S; Strawn JR J Am Acad Child Adolesc Psychiatry; 2022 Jan; 61(1):29-31. PubMed ID: 34767918 [TBL] [Abstract][Full Text] [Related]
14. A Randomized Controlled Trial of Combinatorial Pharmacogenetics Testing in Adolescent Depression. Vande Voort JL; Orth SS; Shekunov J; Romanowicz M; Geske JR; Ward JA; Leibman NI; Frye MA; Croarkin PE J Am Acad Child Adolesc Psychiatry; 2022 Jan; 61(1):46-55. PubMed ID: 34099307 [TBL] [Abstract][Full Text] [Related]
16. Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting. Hall-Flavin DK; Winner JG; Allen JD; Carhart JM; Proctor B; Snyder KA; Drews MS; Eisterhold LL; Geske J; Mrazek DA Pharmacogenet Genomics; 2013 Oct; 23(10):535-48. PubMed ID: 24018772 [TBL] [Abstract][Full Text] [Related]
17. Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression. Rothschild AJ; Parikh SV; Hain D; Law R; Thase ME; Dunlop BW; DeBattista C; Conway CR; Forester BP; Shelton RC; Macaluso M; Brown K; Lewis D; Gutin A; Jablonski MR; Greden JF Psychiatry Res; 2021 Feb; 296():113649. PubMed ID: 33360967 [TBL] [Abstract][Full Text] [Related]
18. Novel Augmentation Strategies in Major Depression. Martiny K Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173 [TBL] [Abstract][Full Text] [Related]
19. Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded, prospective study. Han C; Wang SM; Kwak KP; Won WY; Lee H; Chang CM; Tang TC; Pae CU J Psychiatr Res; 2015; 66-67():84-94. PubMed ID: 26013203 [TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics guided versus standard antidepressant treatment in a community pharmacy setting: A randomized controlled trial. Papastergiou J; Quilty LC; Li W; Thiruchselvam T; Jain E; Gove P; Mandlsohn L; van den Bemt B; Pojskic N Clin Transl Sci; 2021 Jul; 14(4):1359-1368. PubMed ID: 33641259 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]